Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F; Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG). Vogt J, et al. Among authors: kuon j. Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30. Oncologist. 2021. PMID: 33687742 Free PMC article.
Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment.
Kuon J, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, Stahlhut K, Heider A, Lordick F, Thomas M; on behalf of the Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG). Kuon J, et al. Oncol Res Treat. 2019;42(12):650-659. doi: 10.1159/000502751. Epub 2019 Oct 21. Oncol Res Treat. 2019. PMID: 31634889
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study.
Kuon J, Blasi M, Unsöld L, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, Stahlhut K, Heider A, Lordick F, Thomas M; Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG). Kuon J, et al. Support Care Cancer. 2022 Apr;30(4):3131-3140. doi: 10.1007/s00520-021-06736-2. Epub 2021 Dec 7. Support Care Cancer. 2022. PMID: 34877613 Free PMC article.
Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis.
Blasi M, Eichhorn ME, Christopoulos P, Winter H, Heußel CP, Herth FJ, El Shafie R, Kriegsmann K, Kriegsmann M, Stenzinger A, Bischoff H, Thomas M, Kuon J. Blasi M, et al. Among authors: kuon j. BMC Pulm Med. 2022 Jun 28;22(1):255. doi: 10.1186/s12890-022-02043-6. BMC Pulm Med. 2022. PMID: 35761214 Free PMC article.
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Christopoulos P, Schneider MA, Bozorgmehr F, Kuon J, Engel-Riedel W, Kollmeier J, Baum V, Muley T, Schnabel PA, Bischoff H, Grohé C, Serke M, Thomas M, Fisch P, Meister M. Christopoulos P, et al. Among authors: kuon j. Lung Cancer. 2018 May;119:48-55. doi: 10.1016/j.lungcan.2018.03.002. Epub 2018 Mar 6. Lung Cancer. 2018. PMID: 29656752
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
Wessels S, Muley T, Christopoulos P, Meister M, Heinzmann-Groth I, Warth A, Herpel E, Hummler S, Klingmüller U, Kuon J, Heussel CP, Eberhardt R, Herth FJF, Winter H, Bischoff H, Stenzinger A, Reck M, Huber RM, Thomas M, Schneider MA. Wessels S, et al. Among authors: kuon j. Transl Lung Cancer Res. 2020 Aug;9(4):1000-1014. doi: 10.21037/tlcr-20-137. Transl Lung Cancer Res. 2020. PMID: 32953480 Free PMC article.
30 results